Population pharmacokinetics (PK) of ritonavir (RTV)-boosted atazanavir (ATV) in HIV-infected and healthy individuals

被引：0
|
作者：
Dickinson, L. [1 ,3 ]
Aarons, L. [2 ]
Back, D. [3 ]
Waters, L. [4 ]
Else, L. [3 ]
Khoo, S. [3 ]
Pozniak, A. [4 ]
Boffito, M. [4 ]
机构：
[1] Royal Liverpool & Broadgreen Univ Hosp Trust, NIHR Biomed Res Ctr, Liverpool, Merseyside, England
[2] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England
[3] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[4] Chelsea & Westminster Fdn Trust, St Stephens Ctr, London, England
来源：
HIV MEDICINE | 2009年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [1] Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected and healthy individuals
    Dickinson, Laura
    Aarons, Leon
    Back, David
    Khoo, Saye
    Else, Laura
    Waters, Laura
    Pozniak, Anton
    Boffito, Marta
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 304 - 305
  • [2] Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
    Dickinson, Laura
    Boffito, Marta
    Back, David
    Waters, Laura
    Else, Laura
    Davies, Geraint
    Khoo, Saye
    Pozniak, Anton
    Aarons, Leon
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1233 - 1243
  • [3] Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David J.
    Khoo, Saye H.
    Pozniak, Anton L.
    Mugyenyi, Peter
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David M.
    Aarons, Leon J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1344 - 1355
  • [4] Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
    Punyawudho, Baralee
    Thammajaruk, Narukjaporn
    Ruxrungtham, Kiat
    Avihingsanon, Anchalee
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (03) : 327 - 332
  • [5] Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents
    Kiser, Jennifer J.
    Rutstein, Richard M.
    Samson, Pearl
    Graham, Bobbie
    Aldrovandi, Grace
    Mofenson, Lynne M.
    Smith, Elizabeth
    Schnittman, Steven
    Fenton, Terry
    Brundage, Richard C.
    Fletcher, Courtney V.
    [J]. AIDS, 2011, 25 (12) : 1489 - 1496
  • [6] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Dailly, Eric
    Tribut, Olivier
    Tattevin, Pierre
    Arvieux, Cedric
    Perre, Philippe
    Raffi, Francois
    Jolliet, Pascale
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 523 - 526
  • [7] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Eric Dailly
    Olivier Tribut
    Pierre Tattevin
    Cédric Arvieux
    Philippe Perré
    François Raffi
    Pascale Jolliet
    [J]. European Journal of Clinical Pharmacology, 2006, 62 : 523 - 526
  • [8] Population pharmacokinetics of boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David
    Khoo, Saye
    Pozniak, Anton
    Byakika-Kibwika, Pauline
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David
    Aarons, Leon
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 995 - 996
  • [9] Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
    Nishijima, Takeshi
    Hamada, Yohei
    Watanabe, Koji
    Komatsu, Hirokazu
    Kinai, Ei
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    [J]. PLOS ONE, 2013, 8 (10):
  • [10] Hyperbilirubinemia during therapy with atazanavir boosted with ritonavir in HIV-infected patients in Lodz region
    Wojcik, Kamila
    Jablonowska, Elzbieta
    [J]. HIV & AIDS REVIEW, 2012, 11 (02): : 54 - 56
12345